Senator Rick Scott, Chairman of the U.S. Senate Special Committee on Aging, has voiced concerns about the United States’ reliance on foreign-manufactured generic prescription drugs. In an opinion piece published in The Hill, Scott described how insufficient oversight in countries such as China is endangering Americans’ health and creating national security risks.
Scott recounted the story of LeRoy Hubley, whose wife and son died after receiving contaminated doses of Chinese-made Heparin while being treated for a genetic kidney disease. He stated, “In December of 2007, LeRoy Hubley endured the most devastating experience of his life. His wife of 48 years and his son died within weeks of each other. The culprit? Contaminated doses of Chinese-made generic drug Heparin that there were taking to treat a genetic kidney disease.”
He added, “Unfortunately, the Hubleys are not the only victims of our country’s over-reliance on foreign-made generic drugs and a broken system that allows overseas manufacturers to duck quality controls.”
According to Scott, about 75 percent of essential drugs used in the U.S. are produced by overseas manufacturers, with China and India among the largest suppliers. He highlighted that “Of the top 100 generic medicines consumed in the U.S., 83 percent of them contain no American-sourced Active Pharmaceutical Ingredients (APIs). That means if you look in your medicine cabinet now, there’s a good chance you’ll find a foreign-made generic drug that includes Active Pharmaceutical Ingredients from overseas.”
Scott argued these quality control issues are an immediate risk for Americans but said they also reveal vulnerabilities in the pharmaceutical supply chain with implications for national security. “These quality-control issues pose an immediate threat to all Americans, but that is only half of a terrifying problem. America’s over-reliance on foreign-made generic drugs presents massive vulnerabilities in the generic drug supply chain, which creates a significant threat to U.S. national security.”
He warned that disruptions from major suppliers could have severe consequences: “Think about it: if Communist China, a self-described enemy of the United States, or India, wants to stop the supply of prescription drugs to the United States, it can do so at any moment.” Scott continued: “If that happens, the U.S. has no plan to keep these generic life-saving drugs needed by millions of Americans available. We will quickly run out, and people will die. Americans on Medicare, Medicaid and our servicemen and women who rely on drugs supplied through the Department of War account for the lion’s share of the United States’ purchase of foreign-made generic drugs and are especially vulnerable to a supply chain disruption of this kind. Not only are we risking lives, we are siphoning U.S. tax dollars through these programs to help fund an enemy nation committed to destroying our very way of life.”
Scott called for action: “If we can’t solve this problem, it is only a matter of time before more American lives are unnecessarily lost. We’ve failed to act to protect access to safe and quality-controlled life-saving drugs that we, our children, and our parents rely on. That must stop now.” He pledged continued efforts through his committee work: “I won’t stop fighting to expose this problem and fix it to protect our seniors and all Americans who rely on generic prescription drugs. The Aging Committee just held our second hearing and will be releasing a report to propose solutions that protect Americans, secure sustainable supply chains for generic drugs, and end the current threat posed by Communist China and India’s stranglehold on this market.”
The full op-ed can be read at The Hill.
